E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 2/1/2024 in the Prospect News Distressed Debt Daily.

Neuragenex Treatment Centers gets interim access to cash collateral

By Sarah Lizee

Olympia, Wash., Feb. 1 – Neuragenex Treatment Centers, LLC received interim approval to access cash collateral, according to an order filed Thursday with the U.S. Bankruptcy Court for the District of Arizona.

The company’s cash collateral motion was approved on an interim basis through Feb. 13.

As adequate protection for debtor’s use of cash collateral, SARC USA, Inc., Frontline Cyber Solutions Corp., Healthcare Information Services, LLC, United Growth Capital Management, LLC, Millrock Investment Fund 1, LLC and Mark Machlis were granted replacement liens against all property of the debtor, including accounts receivable, equipment and inventory and any and all proceeds generated from those in the same priority as their prepetition liens.

The Mesa, Ariz.-based company owns and operates medical pain treatment centers in several states. The company filed bankruptcy on Jan. 26 under Chapter 11 case number 24-00631.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.